Regulatory Resources Logo
  • Home Icon
  • Search Icon
Regulatory Resources Logo
  • Home Icon
  • Search Icon

Regulatory Resources

Archive - Consolidated Appropriations Act

2023

3-27-23: CMS Updates Prescription Drug Data Collection Reporting Resources and Tools

2022

8-26-22: Final Surprise Billing Rules
8-19-22: Federal Agencies Issue FAQs on No Surprises Act and Transparency in Coverage Implementation

2021

12-27-21: Comprehensive Disclosure Rules for Health Plan Brokers and Consultants
12-27-21: No Surprises Act: ID Cards, Plan Documents, Advance EOBs and Continuity of Care
12-27-21: No Surprises Act: Providing a Price Comparison Tool for Healthcare Consumers
11-17-21: New Prescription Drug and Health Care Spending Interim Final Rule
11-1-21: Feds Provide Non-Enforcement, Grace Period and More Flexibility for RX/Medical Data Reporting Under FAQ Part 56
9-16-21: Proposed Federal Regs Issued for Plan and Insurer Reporting Requirements on Air Ambulance Claims
8-24-21: Federal Agencies Issue New FAQs on Transparency in Coverage and No Surprises Act Implementation and Delayed Enforcement
7-19-21: No Surprises Act: Providing a Price Comparison Tool for Healthcare Consumers
7-13-21: Requirements Related to Surprise Billing: Part I Interim Final Rules
7-1-21: Federal Agencies Issue the First of Several Rules Implementing the No Surprises Act
5-25-21: No Surprises Act: ID Cards, Plan Documents, Advance EOBs and Continuity of Care
5-25-21: No Surprises Act: Protections for Members
1-20-21: New Reporting on Pharmacy Benefits and Drug Costs Required
1-20-21: New Comprehensive Disclosure Rules for Health Plan Brokers and Consultants
1-20-21: Legislation Prohibits ‘Gag’ Clauses on Price and Quality Information
01-1-21: Requirements Related to Surprise Billing
01-1-21: Temporary Special Rules for Health and Dependent Care FSAs

2020

12-27-20: Requirements Related to Surprise Billing; Part II Interim Final Rules and Technical Guidance No. 2021-01
12-27-20: Consolidated Appropriations Act (CAA)
12-27-20: Legislation Prohibits ‘Gag’ Clauses on Price and Quality Information 
12-27-20: 2020 New Reporting on Pharmacy Benefits and Drug Costs Required